Scottish Medical Journal 22:241.[Web of Science ] , [Google Scholar])
Novel GLP-1R co-therapies The GLP-1R agonists exenatide and liraglutide have promising effects on both glucose and energy homeostasis in T2DM patients
However, patients with palpable thyroid masses, unexplained weight loss, voice changes, or a strong personal or family history of medullary thyroid cancer should undergo thyroid imaging before starting semaglutide, per FDA guidance
Its confusing to navigate and lacks some basic features that would be helpful
You can u003ca href=u0022#can-i-use-my-hsa-for-semaglutide-or-tirzepatideu0022u003euse your HSAu003c/au003e to pay for GLP-1 medication as long as it is prescribed for a legitimate medical condition such as obesity, insulin resistance, type 2 diabetes, or metabolic dysfunction